Skip to main content
GoodRx Pharma Direct logo

Copay and Savings Solutions

GoodRx provides an integrated custom segmentation module, called Patient Navigator, that guides and enrolls eligible patients into drug manufacturer savings and support programs.

Mobile app displaying a $25 prescription price with insurance

The Patient Navigator module on GoodRx helps drive patients to a variety of patient access and affordability resources

  • an eye icon

    Prominent placement on GoodRx

    Custom module embedded prominently on a drug’s GoodRx price page.

  • High-intent audiences icon

    Highly qualified patients

    Connects and enrolls highly qualified patients into copay card or patient support programs.

  • Key data and insights

    Integrated and personalized segmentation flows based on customizable criteria can unlock data and insights on target patient populations.

GoodRx helps patients start and stay on therapy

65% of patients first learned about a manufacturer savings program on GoodRx.1

1 GoodRx Effect White Paper 2023

Audience and Reach

  • 1 in 3

    Americans visit GoodRx annually2

  • 1.3M+

    HCPs reached annually3

  • 85%

    patients visiting GoodRx drug price pages have a prescription in hand4

2GoodRx internal data on audience site visits 2025; 3GoodRx internal audience data 2025; 4Visitor Baseline Study 2024

High-intent audiences

GoodRx is a trusted destination where providers and patients actively evaluate treatment options and make healthcare decisions. 

With GoodRx proprietary audience intelligence and real-world healthcare data, drug manufacturers can identify and engage relevant audiences beyond traditional targeting approaches. 

AI-driven personalization delivers continuously optimized experiences that improve engagement across the patient journey.

woman holding a pill bottle and looking at a computer

Impact

  • >10%

    Rx lift on campaigns on average.4

  • reduced prescription wait time icon

    3-8 weeks

    GoodRx Pharma Direct helps patients start therapy 3-8 weeks sooner.5

  • An image of a patient with a checkmark.

    6x NBRx

    Up to 6x New-to-Brand conversion with connected HCP and direct-to-patient campaigns.6

4IQVIA Data 2024 and 2024; 5IQVIA Data 2024 and 2025; 6IQVIA Data 2024 and 2026

WHITE PAPER

Reaching patients with self-pay pricing to enable retention, re-engagement, and improved access to therapy.

GoodRx PharmaDirect white paper about reaching patients with self-pay pricing

Get in touch with our sales team

Learn how GoodRx industry solutions work for your business.

Optional

By clicking Submit, you agree to the GoodRx Terms of Use(opens in a new tab) and Privacy Policy, and you consent to receive marketing communications from GoodRx.